|
BRD2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.05409999973905E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.23199999979562E-07 |
| Normal-vs-Stage2 |
1.216820E-04 |
| Normal-vs-Stage3 |
9.640200E-04 |
| Normal-vs-Stage4 |
1.077030E-03 |
| Stage1-vs-Stage2 |
6.447200E-01 |
| Stage1-vs-Stage3 |
3.868400E-01 |
| Stage1-vs-Stage4 |
9.765400E-01 |
| Stage2-vs-Stage3 |
6.793600E-01 |
| Stage2-vs-Stage4 |
7.420400E-01 |
| Stage3-vs-Stage4 |
5.526200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.40989999997121E-06 |
| Normal-vs-AfricanAmerican |
3.58230000000459E-05 |
| Normal-vs-Asian |
2.880200E-02 |
| Caucasian-vs-AfricanAmerican |
6.005400E-01 |
| Caucasian-vs-Asian |
7.316600E-01 |
| AfricanAmerican-vs-Asian |
8.611000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.14380002428305E-09 |
| Normal-vs-Female |
1.763850E-03 |
| Male-vs-Female |
2.100100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.01729999999412E-05 |
| Normal-vs-Extreme_Weight |
7.59770000247073E-08 |
| Normal-vs-Obese |
6.19450000000077E-05 |
| Normal-vs-Extreme_Obese |
1.361350E-04 |
| Normal_Weight-vs-Extreme_Weight |
5.317000E-01 |
| Normal_Weight-vs-Obese |
4.208200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.485600E-01 |
| Extreme_Weight-vs-Obese |
1.051830E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.223400E-01 |
| Obese-vs-Extreme_Obese |
2.229800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.923680E-02 |
| Normal-vs-Age(41-60Yrs) |
4.30399999999942E-05 |
| Normal-vs-Age(61-80Yrs) |
1.50040000423957E-08 |
| Normal-vs-Age(81-100Yrs) |
1.50506999999633E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.290000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.871500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.758330E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.536440E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.613600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.618200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.89750000051592E-07 |
| Normal-VS-Type2 PRCC |
1.18970000517749E-08 |
| Normal-VS-KIRP CIMP |
5.439600E-02 |
| Normal-VS-Unclassified PRCC |
9.631500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
8.499900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.448000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.705200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.690100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.012420E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.960200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.56830001710284E-10 |
| Normal-vs-N1 |
1.422070E-02 |
| Normal-vs-N2 |
1.535090E-03 |
| N0-vs-N1 |
1.432210E-02 |
| N0-vs-N2 |
5.871200E-01 |
| N1-vs-N2 |
3.004400E-03 |
|
|
